BioRestorative Therapies Inc (BRTX)

[badshah]

From the 3/20 filing...

Item 7.01 Regulation FD Disclosure.
Cautionary Information Regarding Trading in the Company’s Securities
The Company cautions that trading in the Company’s securities during the pendency of the Chapter 11 Case is highly speculative and poses substantial
risks. Trading prices for the Company’s securities may bear little or no relationship to the actual recovery, if any, by the holders of the Company’s securities in the Chapter 11 Case.

This is standard language for a Chap 11 case...

Based on the values for the Company’s business contemplated by the Asset Purchase Agreement referred to herein, the Company expects that existing Company stockholders will receive no recovery at the end of the Chapter 11 Case, consistent with legal priorities.

This can be interpreted in several ways...one way as the naysayer said "the company expects the APA to come up with just enough funds for those above the stockholders and the latter get zilch"

Another interpretation is that "Based on the values for the Company’s business contemplated by the Asset Purchase Agreement referred to herein bla bla bla...but a new and much higher valued APA than that referred to herein could tell a different story ??? After all, most unbiased observers will agree that a company with a Phase III drug about to go into testing this summer is worth a lot more than a few million $ ??? and that is not counting their drugs for bellicose folks...